Acetamide, 2,2,2-trifluoro-N-(1-methylpiperidin-4-yl)-

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: Acetamide, 2,2,2-trifluoro-N-(1-methylpiperidin-4-yl)-
• 英文别名: 2,2,2-trifluoro-N-(1-methylpiperidin-4-yl)acetamide
• 化学式: C₈H₁₃F₃N₂O
• mdl: MFCD16039431
• 分子量: 210.2
• InChiKey: OJABXDJVKUMDKU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.2
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.875
• 拓扑面积：
  32.3
• 氢给体数：
  1
• 氢受体数：
  5

文献信息

• FUNCTIONALLY-MODIFIED OLIGONUCLEOTIDES AND SUBUNITS THEREOF
  申请人：Sarepta Therapeutics, Inc.

  公开号：US20140330006A1

  公开（公告）日：2014-11-06

  Functionally-modified oligonucleotide analogues comprising modified intersubunit linkages and/or modified 3′ and/or 5′-end groups are provided. The disclosed compounds are useful for the treatment of diseases where inhibition of protein expression or correction of aberrant mRNA splice products produces beneficial therapeutic effects.

  提供了包含修改的亚单位间连接和/或修改的3'和/或5'-末端基团的功能修饰寡核苷酸类似物。所公开的化合物对于治疗需要抑制蛋白质表达或纠正异常mRNA剪接产物以产生有益治疗效果的疾病是有用的。
• [EN] PESTICIDALLY ACTIVE 1,2,4-TRIAZOLE DERIVATIVES<br/>[FR] DÉRIVÉS DE 1,2,4-TRIAZOLE ACTIFS À ACTION PESTICIDE
  申请人：SYNGENTA PARTICIPATIONS AG

  公开号：WO2017097927A1

  公开（公告）日：2017-06-15

  The present invention relates to 1,2,4-triazole derivatives, to processes for preparing them, to intermediates for preparing them, to pesticidli, in particular insecticidal, acaricidal, molluscicidal and nematicidal compositions comprising those derivatives and to methods of using them to combat and control pests such as insect, acarine, mollusc and nematode pests.

  这项发明涉及1,2,4-三唑衍生物，涉及制备它们的方法，制备它们的中间体，包括这些衍生物的杀虫剂，特别是杀虫剂、杀螨剂、杀软体动物剂和杀线虫剂组合物，以及使用它们来对抗和控制昆虫、螨虫、软体动物和线虫等害虫的方法。
• PYRROLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
  申请人：Barth Francis

  公开号：US20070149596A1

  公开（公告）日：2007-06-28

  The invention concerns compounds of formula (I): Wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 and R 9 are as defined herein. The invention also concerns the method for preparing said compounds and their therapeutic use.

  该发明涉及式(I)的化合物：其中R1、R2、R3、R4、R5、R6、R7、R8和R9如本文所定义。该发明还涉及制备所述化合物的方法及其治疗用途。
• NEW PYRIDONE DERIVATES WITH MCH ANTAGONISTIC ACTIVITY AND MEDICAMENTS COMPRISING THESE COMPOUNDS
  申请人：STENKAMP Dirk

  公开号：US20120010185A1

  公开（公告）日：2012-01-12

  The present invention relates to compounds of general formula I wherein the groups and radicals B, k, L, U, V, W, X, Y, Z, R 1 , R 2 , have the meanings given in claim 1 . Moreover the invention relates to pharmaceutical compositions containing at least one compound according to the invention. By virtue of their MCH-receptor antagonistic activity the pharmaceutical compositions according to the invention are suitable for the treatment of metabolic disorders and/or eating disorders, particularly obesity, bulimia, anorexia, hyperphagia and diabetes.

  本发明涉及一般式I的化合物，其中B、k、L、U、V、W、X、Y、Z、R1、R2的基团和基团具有权利要求1中给出的含义。此外，本发明还涉及含有至少一种根据本发明的化合物的制药组合物。由于它们的MCH受体拮抗活性，本发明的制药组合物适用于治疗代谢紊乱和/或进食障碍，特别是肥胖症、暴食症、厌食症、过度进食和糖尿病。
• PERIPHERALLY RESTRICTED DIPHENYL PURINE DERIVATIVES
  申请人：RESEARCH TRIANGLE INSTITUTE

  公开号：US20150031689A1

  公开（公告）日：2015-01-29

  The invention provides compounds capable of acting as antagonists at cannabanoid receptors according to the following formula: Such compounds may be used to treat conditions for which the cannabinoid receptor system has been implicated, such as obesity, liver disease, diabetes, pain, and inflammation.

  该发明提供了能够作为大麻素受体拮抗剂的化合物，其化学式如下：这些化合物可用于治疗大麻素受体系统被涉及的疾病，如肥胖症、肝病、糖尿病、疼痛和炎症等。